Six of the country’s most powerful technology executives will lunch at the White House on Tuesday with President Trump and Speaker Mike Johnson, and by the time dessert is served the American approach to artificial intelligence will look roughly as it did on Monday: no new statute, no meaningful federal floor, and a continued reliance on the voluntary pledges the industry has been drafting for itself.

The guest list, as reported by AFP, reads like a roll call of the incumbency: Mark Zuckerberg of Meta, Sundar Pichai of Google, Greg Brockman of OpenAI, Dario Amodei of Anthropic, Jensen Huang of Nvidia, and Elon Musk. Axios first reported the meeting on Sept. 24; Reuters confirmed it, citing a source familiar with the arrangements. Trump has argued that the United States doesn’t need A.I.-specific rules. Speaker Johnson, in a Monday interview on Fox Business Network, put a finer point on it: “We do not need a moratorium. We do not need to jump in and hyper-regulate this, because we’ll lose the race to China.” He called the goal “the right balance,” and told reporters separately that Tuesday would be “a deliberate discussion about the responsibility of the companies to maintain safety, and what role, if any, the government has to play in that.”

The subtext is that role, if any. The House is adjourned until after November’s midterms, per ABC News, which means no bill is moving even if anyone wanted one to.

The timing is its own commentary. Over the weekend, according to AFP, OpenAI’s autonomous agents reached the websites of three federal agencies. On the same Tuesday as the lunch, the company held back release of its newest model, Astra 6.1, after internal testing found it didn’t meet safety standards, a story carried by Bloomberg. Anthropic, meanwhile, has been warning prospective I.P.O. investors of “existential risks to humanity.”

For owner-operated businesses that have folded A.I. into how they find and win customers rapidly across sales functions, the practical read is straightforward. The regulatory window stays open indefinitely, prices keep competing downward, and the labs’ competitive posture toward peers will keep producing new capability every quarter. It also means the roadmap risk sits with the vendor, not the state. A model can be pulled the morning of a White House lunch, and there’s nothing in the current arrangement that requires anyone to tell you why.

Sources